Frank Fokta

Title: Frank Fokta: Innovator in Immune-Modulating Particles

Introduction

Frank Fokta is a notable inventor based in Northbrook, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of immune-modulating particles. His innovative work has led to the creation of a unique method for preparing pharmaceutical compositions that can enhance immune tolerance.

Latest Patents

Frank Fokta holds a patent for a "Process for the preparation of tolerizing immune-modulating particles." This patent outlines a method for creating polymer-encapsulated gliadin particles that can modulate immune responses. His invention is crucial for advancing therapeutic strategies in immunology.

Career Highlights

Frank Fokta is currently associated with Cour Pharmaceuticals Development Company, Inc. His role at the company allows him to apply his expertise in developing cutting-edge pharmaceutical solutions. With a focus on immune modulation, he is at the forefront of research that aims to improve patient outcomes.

Collaborations

Frank has collaborated with notable colleagues, including Ryan Pearson and Daniel R Getts. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Frank Fokta's contributions to the field of immune-modulating particles exemplify the impact of innovative thinking in pharmaceuticals. His work continues to pave the way for advancements in immune therapies, showcasing the importance of research and collaboration in the scientific community.